The Latest from Medicare

Welcome to our article summary! In this concise overview, we will distill the key points and insights from the original piece, providing you with a clear understanding of the main themes and arguments. Whether you're looking for a quick recap or a deeper insight into the topic, this summary will highlight the essential information you need to know. Let's dive in! You can contact Medicare by calling 1-800-MEDICARE (1-800-633-4227) or using live chat to talk with a real person.[7][2][3] This service is available 24 hours a day, 7 days a week, except on some federal holidays.[7][2][3][6] TTY users can call 1-877-486-2048 for help if they are deaf or hard of hearing.[2][3][7] When you call, you'll go through an automated system that guides you step by step, and then you can speak to a live agent for questions about coverage, claims, premiums, deductibles, or enrolling in a plan.[2][3][6] Besides the phone, you can get information on the Medicare website, log into your personal Medicare account online, or use the 24/7 live chat feature.[2][4][6] For specific situations, other numbers might help too. For example, call the Social Security Administration at 1-800-772-1213 (TTY: 1-800-325-0778) weekdays from 8 a.m. to 7 p.m. local time for name changes or Social Security Disability Insurance questions.[3][5] State Medicaid offices can be reached at 1-877-267-2323 (TTY: 1-800-877-8339) if you need help with out-of-pocket Medicare costs.[2] Private plans like Blue Cross and Blue Shield of New Mexico Medicare have their own lines, such as 1-866-286-6159 (TTY 711), open 8 a.m. to 8 p.m. local time, 7 days a week, with some limits on weekends and holidays from April 1 to September 30.[1] Help with your insurance? https://tally.so/r/n012P9

The Latest Medical News

A Summary of The Latest Medical News: The **FDA has expanded approval of Addyi (flibanserin)** to include **postmenopausal women under age 65** who are living with low sexual desire, making it the **first and only once-daily oral pill** approved for low libido in this age group.[1][3][5][8] This move builds on Addyi’s original **2015 approval for premenopausal women** with hypoactive sexual desire disorder (HSDD), a condition marked by persistently low sexual desire that causes personal distress and is not explained by relationship issues, medical illness, or other drugs.[1][3][8] With the new decision, **millions of postmenopausal women now have an FDA‑approved medical option** for HSDD, a problem that experts say affects a large share of women after menopause and has historically been underdiagnosed and undertreated.[3][4][5][8] Addyi is a **non-hormonal medication** that works in the brain on key neurotransmitters involved in sexual response, rather than by replacing estrogen or testosterone, which may make it an option for women who cannot or prefer not to use hormone therapy.[1][3][5][8] Women who use Addyi take a **100 mg tablet once each night** and are advised to work closely with a healthcare professional to confirm that their symptoms are truly HSDD and to decide whether the benefits outweigh the risks in their individual situation.[1][3][8][9] Clinical trials — described by the manufacturer as among the **largest and most rigorous ever conducted in women’s sexual health** — found that Addyi modestly increased sexual desire and reduced the distress linked to low libido for some women, which supported this new approval.[1][3][8] However, **side effects and safety considerations are important**: Addyi can cause low blood pressure, fainting, dizziness, and sleepiness, and women are instructed to discuss alcohol use, drug use, mental health history, pregnancy plans, and any tendency toward low blood pressure with their clinician before starting the medication.[1][5][8][9] Experts in sexual medicine and menopause have called the decision a **“historic first” for women’s sexual health**, arguing that it recognizes that sexuality does not end with menopause and that older women deserve the same evidence-based options for sexual wellbeing as younger women.[1][3][4][5] For women who are unsure whether Addyi is right for them, specialists emphasize a **holistic approach**: evaluating relationship dynamics, stress, mood, sleep, medications, and hormonal status, and considering alternatives such as counseling, sex therapy, lifestyle changes, and — when appropriate — hormonal treatments alongside or instead of medication like Addyi.[3][5][6][8] Help with your insurance? https://tally.so/r/n012P9

The Latest Medical News

A Summary of The Latest Medical News: Uterine Fibroids Tied to Higher Heart Disease Risk: What This New Study Means for Women **A major new study is drawing a direct line between uterine fibroids and long‑term heart health, suggesting these common growths may be more than just a gynecologic concern.**[3][4] Researchers analyzed health data from more than 2.7 million women in the United States over a 10‑year period, comparing those diagnosed with uterine fibroids to women without them.[3][4] They found that women with fibroids had an **81% higher risk** of developing cardiovascular disease, including coronary artery disease, stroke‑related conditions, and peripheral artery disease.[1][2][3][4] Over a decade of follow‑up, **5.4% of women with fibroids experienced a cardiovascular event, compared with 3.0% of women without fibroids**, confirming a sustained elevation in risk long after the initial fibroid diagnosis.[1][4] The increased risk showed up **across all racial and ethnic groups**, and the relationship was especially strong in women under 40, who were more than three and a half times more likely to develop heart disease if they had fibroids.[2][3] Uterine fibroids themselves are **benign (noncancerous) tumors** that grow from the muscle tissue of the uterus and are extremely common by midlife, often causing symptoms like heavy bleeding, pain, or pressure—but in many cases, they are discovered incidentally.[1][3] What makes this new research noteworthy is the idea that **fibroids may act as a marker for higher cardiovascular risk**, flagging women who could benefit from earlier or more intensive heart health monitoring.[1][2][4] Scientists suspect the connection may be driven by **shared biological pathways**: processes such as abnormal smooth muscle growth, buildup of connective tissue, inflammation, and calcification are seen both in fibroid development and in atherosclerotic cardiovascular disease.[1][3][4] The study’s authors and outside experts caution that more research is needed before doctors formally change heart disease risk calculators or screening guidelines, but they agree the strength and consistency of the association are hard to ignore.[3][4][6] For now, the finding reframes fibroids as **not just a reproductive health issue**, but a potential red flag for underlying vascular or cardiovascular problems, underscoring the need for more comprehensive care that considers both gynecologic and heart health together.[1][3][5] For women living with fibroids, this research supports having proactive conversations with healthcare providers about blood pressure, cholesterol, lifestyle factors, and long‑term heart disease prevention—rather than focusing solely on managing fibroid symptoms.[3][5] Help with your insurance? https://tally.so/r/n012P9

The Latest Medical News

A Summary of The Latest Medical News: A new study is shining a spotlight on the way our **gut microbiome** may help protect against type 2 diabetes by producing a powerful, diabetes-fighting molecule. Researchers have identified a microbial metabolite called **trimethylamine (TMA)** that appears to help lower **insulin resistance**, a key driver of type 2 diabetes.[2][3][7] TMA is produced in the gut when bacteria break down **choline**, a nutrient found in foods like **eggs, fish, and meat**.[2][3][7] In lab and animal studies, TMA was shown to **block an immune protein called IRAK4**, which normally helps trigger inflammation in response to a high-fat or unbalanced diet.[2][3][4][6][7] By dialing down this inflammation, TMA helped **restore insulin sensitivity** and improve blood sugar control, even under high-fat diet conditions.[2][3][4][6][7] The researchers found that either **boosting TMA** or directly blocking **IRAK4**—genetically or with drugs—produced similar benefits, suggesting multiple potential paths for future treatments.[2][3][4][6] This discovery flips the usual story about gut metabolites like TMA, which have often been viewed as harmful because their byproduct, TMAO, has been linked to heart disease risk.[2][3][4][6][7] Instead, this work highlights how **diet–microbiome interactions** can generate molecules that actively **protect metabolic health**, offering a fresh angle for type 2 diabetes prevention and therapy.[2][3][4][7] Looking ahead, scientists say that **nutrition strategies** or **new medications** designed to safely increase beneficial TMA activity—while managing its conversion to TMAO—could open the door to novel ways of tackling insulin resistance in people at risk for or living with type 2 diabetes.[2][3][4][6][7] Help with your insurance? https://tally.so/r/n012P9

The Latest Medical News

A Summary of The Latest Medical News: Polyphenol-rich foods – like coffee, berries, cocoa, and olive oil – may quietly be giving your heart a long-term health boost, according to new research. Researchers tracking more than 3,100 adults over about a decade found that people who regularly ate **polyphenol-rich foods** had a **slower rise in cardiovascular risk as they aged**.[1][3] Polyphenols are natural plant compounds found in everyday foods such as **tea, coffee, berries, cocoa, nuts, whole grains, and olive oil**, and they’ve been linked to benefits for the **heart, brain, and gut**.[1][3] In this large UK study, participants whose diets were highest in certain polyphenols tended to have **healthier blood pressure and cholesterol levels**, including higher levels of HDL, the so‑called “good” cholesterol, which contributed to **lower predicted heart disease risk scores**.[1][3] Scientists also measured **polyphenol breakdown products in urine** and found that people with higher levels of these metabolites – especially from flavonoids and phenolic acids – had **lower cardiovascular risk**.[1][3] Instead of just counting total polyphenol grams, the team used a new **polyphenol dietary score** that looks at overall eating patterns, capturing how a variety of foods like berries, coffee, nuts, whole grains, cocoa, and olive oil work together in the diet.[1][3] That pattern-based score turned out to be **more strongly linked to heart health** than simply estimating total polyphenol intake, suggesting that what really matters is the **overall mix of plant foods you eat regularly**, not one “magic” ingredient.[1][3] Researchers say that even **small, consistent shifts** toward more polyphenol-rich foods – like adding a handful of berries, swapping in nuts for snacks, choosing whole grains, or using olive oil more often – may help **protect the heart over time**.[1][3] While cardiovascular risk naturally goes up with age, people who stuck with these polyphenol-rich eating habits saw that risk **climb more slowly** during the 11-year follow-up period.[1][3] Experts caution that this kind of research shows **association, not proof of cause and effect**, but they say the findings add to a growing body of evidence that plant-forward, polyphenol-rich diets are a **simple, practical way to support long-term heart health**.[1][3][5] Help with your insurance? https://tally.so/r/n012P9

The Latest Medical News

A Summary of The Latest Medical News: # GLP-1 Weight Loss Drugs and Cancer Risk: What the Latest Evidence Shows **GLP-1 drugs like Wegovy may not significantly alter the risk of obesity-related cancers, according to a new analysis of existing studies.**[1][2] This finding challenges some earlier optimism about these popular medications, which are widely used for weight loss and diabetes management. **Obesity itself weakens the body's cancer-fighting immune system, but GLP-1s show promise in animal studies.**[1] Duke University researcher Erika J. Crosby found that in obese mice, a cancer vaccine failed to protect against breast tumors, unlike in lean mice. **However, when obese mice received GLP-1 drugs, tumors grew more slowly, and their cancer risk dropped sharply—even on a high-fat diet.**[1] Crosby noted this effect went beyond weight loss, possibly by resetting metabolism and recalibrating immune responses to recognize cancer threats. **In human data from type 2 diabetes patients, GLP-1 receptor agonists (GLP-1RAs) reduced risks for 10 out of 13 obesity-associated cancers compared to insulin.**[2] These included esophageal, colorectal, endometrial, gallbladder, kidney, liver, ovarian, pancreatic cancers, plus meningioma and multiple myeloma. **No risk reduction was seen for postmenopausal breast cancer or thyroid cancer when comparing GLP-1RAs to insulin.**[2] Against metformin, GLP-1RAs showed no decreased risk for any cancers and were linked to higher kidney cancer risk (HR 1.54).[2] **A UC San Diego study of colon cancer patients found those on GLP-1s had dramatically lower death rates—less than half within five years.**[3] This benefit was strongest in those with BMI over 35, potentially due to reduced inflammation, better insulin sensitivity, or direct anti-tumor effects. **The American Cancer Society notes some studies suggest GLP-1s may lower risks for breast, prostate, lung, pancreatic, colon, and liver cancers.**[4] Animal studies flag a higher risk of rare medullary thyroid cancer (MTC), leading to warnings against use in those with MTC history or MEN2 syndrome.[4] **MD Anderson experts highlight evidence that GLP-1 agonists like semaglutide may cut cancer risk beyond weight loss alone.**[5] Memorial Sloan Kettering reports a small increased kidney cancer risk with these drugs, advising doctor discussions.[6] **Thyroid cancer concerns persist in some meta-analyses, though many studies show no elevated risk for differentiated thyroid cancer.**[7] **Overall, while GLP-1s offer metabolic benefits that could indirectly protect against obesity-linked cancers, human evidence is mixed and calls for more clinical trials.**[1][2][3] Patients should weigh personal risks with healthcare providers amid evolving research. Help with your insurance? https://tally.so/r/n012P9

The Latest Medical News

A Summary of The Latest Medical News: Cheese Lovers Rejoice: Japanese Study Links Weekly Cheese Eats to Lower Dementia Risk** A fresh study out of Japan suggests that munching on cheese at least once a week could slash dementia risk by 21-24% in older adults.[1][2][3] **The Study Breakdown** Researchers tracked nearly 8,000 community-dwelling Japanese adults aged 65 and up from the JAGES 2019 survey, matching cheese eaters (at least weekly) with non-eaters one-to-one.[1][2] Over three years, dementia hit 3.4% of cheese consumers (134 cases) versus 4.5% of non-consumers (176 cases), dropping absolute risk by 1.06 percentage points.[1][3] Cox analysis showed a 24% lower hazard initially, holding at 21% after tweaking for diet like fruits, veggies, and meats.[1] **What Kind of Cheese?** Processed cheese dominated at 82.7%, with most folks (72%) eating it just 1-2 times weekly; fancier types like Camembert (7.8%) and blue (0.5%) were rarer.[1] **Why Might Cheese Help?** Bioactives like vitamin K2, peptides, probiotics, and antioxidants in cheese could shield the brain via anti-inflammatory and vascular perks, though processed versions might pack less punch.[1] **Japan's Low Dairy Scene** With Japan averaging just 2.6 kg cheese per person yearly (vs. U.S. 17.4 kg), even modest habits stood out statistically—no dose-response checked, though.[1][3] **Caveats and Funding Flag** This observational cohort can't prove cause; confounders linger despite adjustments, and Meiji (a dairy seller) funded it—past studies clash, like one government-backed Japanese one finding zilch.[1][3][4][5] **Bigger Picture from Elsewhere** A Swedish 25-year study tied high-fat cheese (>50g/day) to 13-17% less Alzheimer's (non-genetic cases); Finland saw 28% drop with cheese alone over 22 years.[4][5] **Takeaway for Your Plate** Modest weekly cheese might nudge brain health in low-dairy crowds, but don't overdo it—balance with whole diet, chat with docs, and await more trials.[1][2][3] Help with your insurance? https://tally.so/r/n012P9